Revolution Medicines, Inc. (RVMD)
NASDAQ: RVMD · Real-Time Price · USD
36.92
-0.52 (-1.39%)
Apr 24, 2025, 9:35 AM EDT - Market open
Revolution Medicines Market Cap
Revolution Medicines has a market cap or net worth of $6.86 billion as of April 24, 2025. Its market cap has increased by 30.61% in one year.
Market Cap
6.86B
Enterprise Value
4.81B
1-Year Change
30.61%
Ranking
Category
Stock Price
$36.92
Market Cap Chart
Since February 13, 2020, Revolution Medicines's market cap has increased from $1.64B to $6.86B, an increase of 317.39%. That is a compound annual growth rate of 31.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 23, 2025 | 6.96B | -13.89% |
| Dec 31, 2024 | 8.08B | 71.26% |
| Dec 29, 2023 | 4.72B | 123.15% |
| Dec 30, 2022 | 2.11B | 14.03% |
| Dec 31, 2021 | 1.85B | -29.43% |
| Dec 31, 2020 | 2.63B | 59.81% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 742.19B |
| UnitedHealth Group | 389.65B |
| Johnson & Johnson | 372.56B |
| AbbVie | 311.50B |
| Novo Nordisk | 276.62B |
| Abbott Laboratories | 223.95B |
| Novartis AG | 211.63B |
| AstraZeneca | 210.34B |